These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 6864687

  • 21. [Calcium ion uptake by the skin fibroblast culture under normal conditions and in systemic diseases of the connective tissue].
    Grozdova MD, Panasiuk AF, Sharlova IL.
    Biull Eksp Biol Med; 1978 Mar; 85(3):287-9. PubMed ID: 307413
    [Abstract] [Full Text] [Related]

  • 22. Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?
    Hagdrup H, Serup J, Tvedegaard E.
    Acta Derm Venereol; 1983 Mar; 63(5):447-9. PubMed ID: 6197850
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H, Tausch G, Eberl R.
    Wien Klin Wochenschr; 1976 Apr 30; 88(9):292-5. PubMed ID: 973388
    [Abstract] [Full Text] [Related]

  • 24. Connective tissue changes in systemic sclerosis and the use of D-penicillamine.
    Jayson MI.
    Agents Actions Suppl; 1979 Apr 30; (5):149-57. PubMed ID: 294132
    [No Abstract] [Full Text] [Related]

  • 25. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.
    Arthritis Rheum; 2002 Nov 30; 46(11):2983-9. PubMed ID: 12428241
    [Abstract] [Full Text] [Related]

  • 26. [D-Penicillamine effect on collagen synthesis and structural maintenance Red Sirius staining with polarized-light examination. The value of this staining in cases of collagen diseases (author's transl)].
    Pieraggi MT, Bonafe JL.
    Ann Pathol; 1982 Nov 30; 2(2):155-7. PubMed ID: 6179525
    [Abstract] [Full Text] [Related]

  • 27. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y, Kohriyama K, Matsui T.
    J Rheumatol; 1999 Nov 30; 26(11):2493-5. PubMed ID: 10555917
    [Abstract] [Full Text] [Related]

  • 28. Treatment of generalized scleroderma: updated results.
    Asboe-Hansen G.
    Acta Derm Venereol; 1979 Nov 30; 59(5):465-7. PubMed ID: 93375
    [Abstract] [Full Text] [Related]

  • 29. Treatment of systemic sclerosis.
    Wigley FM.
    Curr Opin Rheumatol; 1992 Dec 30; 4(6):878-86. PubMed ID: 1457284
    [Abstract] [Full Text] [Related]

  • 30. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G.
    Acta Med Acad Sci Hung; 1978 Dec 30; 35(3-4):201-11. PubMed ID: 756110
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nodular scleroderma in systemic sclerosis under D-penicillamine therapy.
    Sasaki T, Denpo K, Ono H, Nakajima H.
    J Dermatol; 1992 Dec 30; 19(12):968-71. PubMed ID: 1293190
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year].
    Kahn MF, Bourgeois P, Brion N, Elleuch M.
    Rev Rhum Mal Osteoartic; 1986 Jan 30; 53(1):35-8. PubMed ID: 3704510
    [Abstract] [Full Text] [Related]

  • 34. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
    Kahl LE, Medsger TA, Klein I.
    J Rheumatol; 1985 Oct 30; 12(5):990-1. PubMed ID: 4087275
    [Abstract] [Full Text] [Related]

  • 35. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M, Jimenez S, Werth VP.
    J Am Acad Dermatol; 2000 Feb 30; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [Abstract] [Full Text] [Related]

  • 36. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
    Santiago B, Galindo M, Rivero M, Pablos JL.
    Arthritis Rheum; 2001 Jul 30; 44(7):1667-76. PubMed ID: 11465719
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis.
    Westergren-Thorsson G, Cöster L, Akesson A, Wollheim FA.
    J Rheumatol; 1996 Aug 30; 23(8):1398-406. PubMed ID: 8856620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.